Hemostatic imbalance in active and quiescent ulcerative colitis

American Journal of Gastroenterology

Volumn 96, Issue 2, 2001, Pages 487-493

  Van Bodegraven, Ad A ^a   Schoorl, Marianne ^b   Baak, Jan P A ^a   Linskens, R K ^a   Bartels, Piet C M ^b   Tuynman, Hans A R E ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Location Alkmaar   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; SERUM ALBUMIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOSCOPY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HISTOPATHOLOGY; HUMAN; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; FOLLOW-UP STUDIES; HEMOSTASIS; HUMANS; LONGITUDINAL STUDIES; MALE; THROMBOPHILIA; TIME FACTORS;

EID: 0035123760     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02325-X     Document Type: Article

References (33)

1. Prothrombotic abnormalities in inflammatory bowel disease
2. Prothrombin fragment 1 + 2, and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases
3. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease
4. The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation
5. Vascular complications of inflammatory bowel disease
6. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis
7. Life histories of patients with ulcerative colitis. A review of 2000 cases
8. Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery?
9. Mucosal capillary thrombi in rectal biopsies
10. Paradoxical response to heparin in 10 patients with ulcerative colitis
11. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease
12. Inherited disorders of coagulation appear to protect against inflammatory bowel disease
13. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces
14. Impaired fibrinolytic capacity in patients with inflammatory bowel disease
15. Low levels of plasminogen activator inhibitor type I in patients with inflammatory bowel disease
16. Fibrinolytic split products, fibrinolysis, and Factor XIII activity in inflammatory bowel disease
17. Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis
18. Comparison of beclomethasone diproprionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis
19. Short-term intraindividual variability in hemostasis factors
20. Intra- and interindividual variability of hemostatic factors, and traditional cardiovascular risk factors in a three-year follow-up
21. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma
22. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma
23. No evidence for a prethrombotic state in stable chronic inflammatory bowel disease
24. Hemostatic abnormalities in inflammatory bowel disease
25. No evidence of activated blood coagulation in Crohn's disease
26. Macrophage procoagulants
27. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation
28. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis
29. Contrasting post-traumatic serial changes for D-Dimer and PAI-1 in critically injured patients
30. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease
31. Drug-induced alterations of hemostasis, and fibrinolysis
32. Interactions of neutrophils and coagulation proteins
33. Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease